Posts

Showing posts with the label Pharma Marketing

Pharma Marketing by 2030 – Asrar Qureshi’s Blog Post #1148

Image
Pharma Marketing by 2030 – Asrar Qureshi’s Blog Post #1148 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1148 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Timur Saglambilek Credit: Mikael Blomkvist Preamble I discussed how pharmaceutical selling is likely to change during the next five years. Now, this is a broad vision of how pharmaceutical marketing may look like by 2030, with a special lens on Pakistan. It is more complex than selling because marketing is the brain and it works for present and future simultaneously. What will change materially by 2030 Omnichannel becomes the default, not “digital vs. rep,” but both. HCPs increasingly want integrated experiences across rep visits, virtual touchpoints, portals, webinars, medical content hubs, and peer channels. Medical and commercial touchpoints will be o...

Ten Tests of Strategy by McKinsey – Asrar Qureshi’s Blog Post #1136

Image
Ten Tests of Strategy by McKinsey – Asrar Qureshi’s Blog Post #1136 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1136 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Mikhail Nilov Credit: RDNE Stock Project Preamble Strategy making is a necessity but in certain corporates, it becomes a favorite pastime among senior managers. There are uncountable strategy meetings, workshops, working groups etc. The strategies that emerge are many a times repeat of the old ones with different words and emphasis on ‘more of the same’. For example, last year we spent one hundred million on customer services, this year we should spend 200 million. Very rarely, new ground is broken. Strategy is a roadmap of the future and must be separated from tactical plan. The frameworks for developing strategy are different. When a strategy ...

Pharmaceutical Marketing – Stuck in the Past – Asrar Qureshi’s Blog Post #1103

Image
Pharmaceutical Marketing – Stuck in the Past – Asrar Qureshi’s Blog Post #1103 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1103 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Antoni Shkraba Credit: Eva Bronzini Credit: Leeloo The First Preamble The pharmaceutical industry is among the most scientifically advanced sectors in the world. It leads in innovation, from cutting-edge drug development to biotech breakthroughs and AI-driven clinical trials. Yet, when it comes to marketing, many companies continue to follow the same old beaten path. The strategies are repetitive, execution is formulaic, and innovation is often conspicuously absent. Despite changing customer behaviors, digital disruption, and growing demand for personalized engagement, pharmaceutical marketing often remains locked in outdated paradigm...

Influence of Gen AI on Pharmaceutical Marketing – Now and in Five Years – Asrar Qureshi’s Blog Post #1088

Image
Influence of Gen AI on Pharmaceutical Marketing – Now and in Five Years – Asrar Qureshi’s Blog Post #1088 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1088 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: fauxels Credit: Polina Tankilevich Credit: This is Engineering Preamble It is a foregone conclusion that the Generative Artificial Intelligence – Gen AI or simply AI – has already started influencing every walk of life. The pace of change is so rapid that it has become difficult to keep adjusting with it. But we must keep pace with the changing landscape to survive respectably or risk to be perished. In this blog post, we see how AI has already influenced pharmaceutical marketing. We shall also try to visualize the next five years and the possible changes that might be coming. My reference is not strictly lo...

Pharma Marketing Over Decades– Asrar Qureshi’s Blog Post #1079

Image
Pharma Marketing Over Decades– Asrar Qureshi’s Blog Post #1079 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1079 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Leeloo The First Credit: Mikael Blomkvist Credit: Timur Saglambilek Preamble Pharmaceutical marketing worldwide has undergone a radical transformation over the past two decades, driven by technological advancements, regulatory changes, shifting patient expectations, and evolving healthcare dynamics. From traditional sales-driven models to digital, data-driven, and patient-centric approaches, the industry has adapted to a rapidly changing landscape. In Pakistan, last three decades have also seen major changes, however, these are not related to technology mostly. I would keep my focus on marketing part, not other areas of pharmaceutical industry. Shift...

Next Generation Marketing Skills – Asrar Qureshi’s Blog Post #1026

Image
Next Generation Marketing Skills – Asrar Qureshi’s Blog Post #1026 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1026 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing our contributions here. Credit: Artem Podrez Credit: Karolina Grabowska Credit: Timur Saglambilek Preamble The marketing landscape is evolving rapidly, driven by technological advancements and changing consumer behaviors. To thrive in this dynamic environment, marketers need to acquire a new set of skills. While consumer companies, rather non-pharma companies, have acquired new marketing tools and techniques, the pharma companies are still sticking to old ways of marketing, mostly.  There are no specific skills for pharma industry in marketing domain, though there are clear indicators in research and development. However, the present relationship between companies and customers ha...

Ethical Issues in Pharmaceutical Marketing – Asrar Qureshi’s Blog Post #1005

Image
Ethical Issues in Pharmaceutical Marketing – Asrar Qureshi’s Blog Post #1005 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1005 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing your contributions here. Credit: Anna Shvets Credit: Eva Bronzini Pharmaceutical Marketing is a different type of marketing because the customer is not consumer. In all other commodities, such as food, appliances, textiles, shoes etc., customer and consumer are the same person, unless someone buys for someone else as a gift which is a fraction of total business. In Pharma marketing, customer is doctor and consumer is patient. Pharma companies are not allowed by law to approach patients directly for selling medicines. Nutritional supplements such as vitamins, health foods, probiotics, energy boosters etc., are not supposed to treat any disease and are therefore allowed to adv...

Status of Pharmaceutical Business in Pakistan 2024 - Part I – Asrar Qureshi’s Blog Post 961

Image
Status of Pharmaceutical Business in Pakistan 2024 – Asrar Qureshi’s Blog Post 961 Dear Colleagues! This is Asrar Qureshi’s Blog Post 961 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing your contributions here. Credit: Anna Shvets Credit: Anna Tarazevich Credit: Arda Kaykisiz Credit: RDNE Stock project I would like to comment on the current state of pharmaceutical business in Pakistan. Before that, I would like to put down the basics first. Pharmaceutical business is among key businesses in Pakistan for two reasons: one, it is directly related to the state of healthcare in the country; and two, it employs hundreds of thousands of people in various roles. For common understanding, I may list down the major stakeholders. Pharmaceutical Industry – comprises of around eight hundred manufacturers of pharmaceutical products and about six hundred manufacturers...

Why do Senior Managers Keep Repeating the Same Mistakes? Part VIII – Asrar Qureshi’s Blog Post #951

Image
Why do Senior Managers Keep Repeating the Same Mistakes? Part VIII – Asrar Qureshi’s Blog Post #951 Dear Colleagues! This is Asrar Qureshi’s Blog Post #951 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing your contributions here. Credit: Andrea Piacquadio Credit: Burst Continued from Previous …… The DM decided to intervene. The DM was a highly seasoned professional who believed in autonomy with defined limits, team building, and maintaining conducive work environment. He had been hearing about things happening in KK’s team but did not intervene as a matter of principle. He was the main member of the selection panel that had hired KK. He had liked KK for his profile and personal attributes that they could see during interview. He had given him this particular team which was stable in sales and more stable in working pattern. He wanted KK to change the pac...